RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+34.16%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$913M
AUM Growth
+$115M
(+14%)
Cap. Flow
-$73.3M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
28.56%
Holding
108
New
15
Increased
30
Reduced
36
Closed
14
Top Buys
| 1 |
Guardant Health
GH
|
$9.4M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$9.14M |
| 3 |
Intuitive Surgical
ISRG
|
$7.09M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.81M |
| 5 |
Cooper Companies
COO
|
$6.43M |
Top Sells
| 1 |
CVS Health
CVS
|
$12.1M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.1M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.05M |
Sector Composition
| 1 | Healthcare | 93.54% |
| 2 | Financials | 0.09% |
| 3 | Energy | 0.09% |
| 4 | Technology | 0.09% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Medtronic
MDT
$120B
| $14.2M | 1.55% |
125,030
-60,188
| -32% | -$6.83M |
|
|
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.7M | 1.5% |
120,000
-28,700
| -19% | -$3.28M |
|
28
Iovance Biotherapeutics
IOVA
$771M
| $13.1M | 1.44% |
475,000
-45,000
| -9% | -$1.25M |
|
29
Neurocrine Biosciences
NBIX
$13.6B
| $12.9M | 1.41% |
120,000
-29,600
| -20% | -$3.18M |
|
30
Glaukos
GKOS
$5.18B
| $12.8M | 1.4% |
235,000
+5,400
| +2% | +$294K |
|
|
31
Guardant Health
GH
$7.44B
| $12.1M | 1.33% |
155,268
+120,268
| +344% | +$9.4M |
|
|
DERM
32
DELISTED
Dermira, Inc.
DERM
| $12.1M | 1.33% |
800,000
+250,700
| +46% | +$3.8M |
|
33
FibroGen
FGEN
$47.2M
| $11.8M | 1.29% |
11,000
-800
| -7% | -$858K |
|
34
MacroGenics
MGNX
$116M
| $11.5M | 1.26% |
1,060,000
+260,627
| +33% | +$2.84M |
|
35
Xencor
XNCR
$590M
| $10.7M | 1.17% |
310,000
+7,477
| +2% | +$257K |
|
|
EPZM
36
DELISTED
Epizyme, Inc
EPZM
| $10.5M | 1.15% |
425,000
-25,028
| -6% | -$616K |
|
|
37
CVS Health
CVS
$93.2B
| $10.4M | 1.14% |
140,214
-163,554
| -54% | -$12.1M |
|
38
HCA Healthcare
HCA
$97B
| $10.3M | 1.13% |
70,000
-5,000
| -7% | -$739K |
|
39
Regeneron Pharmaceuticals
REGN
$60.1B
| $10.1M | 1.11% |
27,000
-18,031
| -40% | -$6.77M |
|
|
ARNA
40
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $9.99M | 1.1% |
220,000
+65,000
| +42% | +$2.95M |
|
41
Exact Sciences
EXAS
$9.76B
| $9.9M | 1.08% |
107,000
-786
| -0.7% | -$72.7K |
|
42
Becton Dickinson
BDX
$54.4B
| $9.25M | 1.01% |
34,850
-29,725
| -46% | -$7.89M |
|
|
AXNX
43
DELISTED
Axonics, Inc. Common Stock
AXNX
| $9.14M | 1% |
+330,000
| New | +$9.14M |
|
44
Edwards Lifesciences
EW
$47.7B
| $8.87M | 0.97% |
114,000
+4,245
| +4% | +$330K |
|
45
Centene
CNC
$13.9B
| $8.8M | 0.96% |
140,000
-35,000
| -20% | -$2.2M |
|
|
AMRN
46
Amarin Corp
AMRN
$304M
| $8.58M | 0.94% |
20,000
| – | – |
|
|
SILK
47
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.46M | 0.93% |
209,381
+84,381
| +68% | +$3.41M |
|
|
STML
48
DELISTED
Stemline Therapeutics, Inc.
STML
| $8.08M | 0.89% |
760,181
+249,158
| +49% | +$2.65M |
|
49
Omnicell
OMCL
$1.51B
| $7.76M | 0.85% |
95,000
+5,000
| +6% | +$409K |
|
50
Agios Pharmaceuticals
AGIO
$2.05B
| $7.64M | 0.84% |
160,000
-85,002
| -35% | -$4.06M |
|